Moritz Widmaier, PhD; Branden Hopkinson, PhD
Senior Product Manager AI & Data Analytics
Introduction to Ultivue’s capabilities for immuno-oncology biomarker programs
Length: 20 minutes
Relevant for
FlexVUE, InSituPlex
Description Branden Hopkinson and Moritz Widmaier will explain how you can get the needed support through your entire development pipeline – from defining and framing your specific scientific question and developing your panel, all the way through to delivering answers that enable your project to move forward.
Meet the hosts
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
PhD in Cellular and Genetic Medicine from the University of Copenhagen. Background in human embryonic stem cells and identification of cell of origin for various types of breast cancer. He joined Ultivue to help drive the message of just how powerful Ultivue’s mIF and same slide H&E are when combined with powerful artificial intelligence.
Want to meet with us? Check out our upcoming events.
Related Content
Case Study: A multiplex immunofluorescence assay to assess immune checkpoint inhibitor-targeted CD8 activation and tumor co-localization in FFPE tissues
Leidos
Getting TiME on Your Side: Defining the future of precision medicine with advanced multiplexed immunofluorescence
Ultivue
Characterizing spatial distribution of immune-cell subsets in Nonalcoholic Steatohepatitis and Primary Sclerosing Cholangitis using a novel 12-plex Ultimapper ® kit
Presented at EASL 2021
Use of Ultivue InSituPlex®Multiplex Immunofluorescence to Localize and Quantify Regulatory T Lymphocytes in Crohn’s Disease and Ulcerative Colitis
High throughput phenotyping and imaging of the TME using the FlexVUE immunofluorescence assay
Ultivue
